When is remdesivir effective for COVID-19?
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the… read more.
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the… read more.
Two newer simplified treatment options are at least as effective as current approaches, according to the results of a world-first international clinical trial into second-line HIV therapy led… read more.
Although the public had been alerted that this winter could be a potentially bad flu season, barely half of Americans said in January that they had received a… read more.
For many children, winter season comes with regular exposure to circulating viruses at school or daycare. And a warm forehead is often one of the first clear signs… read more.
When Srikanth Singamaneni and Guy Genin, both professors of mechanical engineering and materials science at the McKelvey School of Engineering at Washington University in St. Louis, established a new collaboration with… read more.
More than one in two cancer patients at a US cancer centre experienced symptoms of long COVID-19 for more than six months after initial infection, according to a… read more.
Two doses of mRNA covid-19 vaccine during pregnancy show significant efficacy against delta and omicron infection in infants under six-months old. They also reduce hospital admission for covid-19… read more.
Five medical organizations are recommending updated best practices for hand hygiene to protect patients and staff in healthcare settings. The recommendations emphasize the importance of healthy skin and… read more.
The findings, published in Proceedings of the National Academy of Sciences (PNAS) today, may mean TB can be cured with shorter treatments. TB typically takes months to treat with multiple… read more.
Professor Colleen Aldous is a research professor at in the School of Clinical Medicine at the University of Kwazulu-Natal in South Africa. She recently described the SAIVE trial… read more.
Colleen Aldous, Professor for Medical Research, University of KwaZulu-Natal explains how the evidence supporting the use of ivermectin for covid-19 came together to tell a compelling story. In… read more.
A new study, published in the European Journal of Public Health based on data from 25,049 children aged three to five, shows an increase in obesity during the COVID-19… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.